lingo.lol is one of the many independent Mastodon servers you can use to participate in the fediverse.
A place for linguists, philologists, and other lovers of languages.

Server stats:

63
active users

#epitwitter

0 posts0 participants0 posts today
Elizabeth Wrigley-Field<p>Hey demography/epi friends: </p><p>What are your favorite measures of the intensity of mortality in one group or the difference/change in mortality across multiple groups or over time? </p><p>Got any cutting-edge innovations (there are a bunch!) or forgotten favorites? I’m compiling a list. I’ve got tons but I want yours!</p><p><a href="https://fediscience.org/tags/demography" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>demography</span></a> <a href="https://fediscience.org/tags/epi" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epi</span></a> <a href="https://fediscience.org/tags/EpiTwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EpiTwitter</span></a> <a href="https://fediscience.org/tags/PopStudies" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>PopStudies</span></a> <a href="https://fediscience.org/tags/mortality" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>mortality</span></a> <a href="https://fediscience.org/tags/longevity" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>longevity</span></a> <a href="https://fediscience.org/tags/MortalityDisparities" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>MortalityDisparities</span></a> <a href="https://fediscience.org/tags/lifespan" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>lifespan</span></a></p>
Luisa N. Borrell<p>PSA loud and clear for the people in the back! <a href="https://mastodon.online/tags/academia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>academia</span></a> <a href="https://mastodon.online/tags/AcademicChatter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AcademicChatter</span></a> <a href="https://mastodon.online/tags/AcademicTwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AcademicTwitter</span></a> <a href="https://mastodon.online/tags/epitwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epitwitter</span></a> <a href="https://mastodon.online/tags/epiverse" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epiverse</span></a> <br>---<br>RT @DrMonicaCox<br>This is how you know who is valued in your organization.</p><p>Whose stories are believed?<br>Whose complaints are responded to?<br>Who is paid the most?<br>Who is given multiple chances?<br>Whose bad behaviors are not addressed?<br>Who benefits from organizational policies?<br><a href="https://twitter.com/DrMonicaCox/status/1646886056724254721" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://</span><span class="ellipsis">twitter.com/DrMonicaCox/status</span><span class="invisible">/1646886056724254721</span></a></p>
Luisa N. Borrell<p><a href="https://mastodon.online/tags/Research" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Research</span></a> &amp; integrity: “Research institutes, funding agencies and scholarly journals can do a lot to foster research integrity, first and foremost by improving the quality of peer review and reforming researcher assessment.” <a href="https://mastodon.online/tags/AcademicTwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AcademicTwitter</span></a> <a href="https://mastodon.online/tags/AcademicChatter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AcademicChatter</span></a> <a href="https://mastodon.online/tags/epitwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epitwitter</span></a> <a href="https://mastodon.online/tags/epiverse" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epiverse</span></a> <br>---<br>RT @RetractionWatch<br>“Why research integrity matters and how it can be improved.”<br><a href="https://www.tandfonline.com/doi/abs/10.1080/08989621.2023.2189010" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">tandfonline.com/doi/abs/10.108</span><span class="invisible">0/08989621.2023.2189010</span></a> <br><a href="https://twitter.com/RetractionWatch/status/1638284537661648898" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://</span><span class="ellipsis">twitter.com/RetractionWatch/st</span><span class="invisible">atus/1638284537661648898</span></a></p>
Luisa N. Borrell<p>I can write a book about this but for now, please share your honest opinion with <a href="https://mastodon.online/tags/NIH" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NIH</span></a> about the challenges PhD graduates face during and post training. <a href="https://mastodon.online/tags/epitwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epitwitter</span></a> <a href="https://mastodon.online/tags/epiverse" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epiverse</span></a> <a href="https://mastodon.online/tags/AcademicTwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AcademicTwitter</span></a> <a href="https://mastodon.online/tags/AcademicChatter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AcademicChatter</span></a> <a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-23-084.html" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://</span><span class="ellipsis">grants.nih.gov/grants/guide/no</span><span class="invisible">tice-files/NOT-OD-23-084.html</span></a> <br>---<br>RT @NIH<br><a href="https://mastodon.online/tags/NIH" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NIH</span></a> is seeking input on challenges affecting retention in the postdoctoral trainee community. Better understanding of these challenges will help NIH support c…<br><a href="https://twitter.com/NIH/status/1625573807955263488" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://</span><span class="ellipsis">twitter.com/NIH/status/1625573</span><span class="invisible">807955263488</span></a></p>
Maciej F Boni :verified:<p>Hi <a href="https://med-mastodon.com/tags/epitwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epitwitter</span></a> <a href="https://med-mastodon.com/tags/epiverse" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epiverse</span></a>, how many <a href="https://med-mastodon.com/tags/COVID" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>COVID</span></a> deaths are we willing to accept per year? As the third year of the <a href="https://med-mastodon.com/tags/pandemic" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>pandemic</span></a> comes to a close, 190,000 Americans will have died of COVID by Feb 28 2023. That's more than for all other infectious disease combined. 1/</p>
Luisa N. Borrell<p>Can we normalize paying an honorarium to minoritized women for talks/presentations? This should be a given… <a href="https://mastodon.online/tags/AcademicTwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AcademicTwitter</span></a> <a href="https://mastodon.online/tags/AcademicChatter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>AcademicChatter</span></a> <a href="https://mastodon.online/tags/epitwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epitwitter</span></a> <a href="https://mastodon.online/tags/epiverse" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epiverse</span></a></p>
Maryn McKenna<p>Hi <a href="https://mastodon.social/tags/MedTwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>MedTwitter</span></a> <a href="https://mastodon.social/tags/epitwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epitwitter</span></a> <a href="https://mastodon.social/tags/IDtwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>IDtwitter</span></a> <a href="https://mastodon.social/tags/publichealth" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>publichealth</span></a> :<br>I'd like to start catching up to what's happening with those hastags and the experience of talking science on here. Are you taking your chats and threads elsewhere, and where? Have your conversations here changed? <br>DMs open!</p>
Maryn McKenna<p>Hi Mastodonians!</p><p> I'd like to start plugging into whatever replacements for <a href="https://mastodon.social/tags/medtwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>medtwitter</span></a> <a href="https://mastodon.social/tags/epitwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epitwitter</span></a> <a href="https://mastodon.social/tags/IDtwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>IDtwitter</span></a> are happening here, if they are. </p><p>What hashtags should I follow and whom should I read?</p><p>If you were/are part of those Twitter communities, are you finding a replacement here (or on another platform?)</p>
Andrew Heiss :rstats:<p>The 8th iteration of my <a href="https://fediscience.org/tags/ProgramEvaluation" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ProgramEvaluation</span></a> and <a href="https://fediscience.org/tags/CausalInference" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>CausalInference</span></a> course is up and live at <a href="https://evalsp23.classes.andrewheiss.com/" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://</span><span class="ellipsis">evalsp23.classes.andrewheiss.c</span><span class="invisible">om/</span></a> ! </p><p>It covers basic econometrics and DAGs, all with <a href="https://fediscience.org/tags/rstats" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>rstats</span></a>, and it's mostly asynchronous with dozens of hours of videos, and the whole thing is Creative Commons-licensed, so do whatever you want with it! <a href="https://fediscience.org/tags/epitwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epitwitter</span></a> <a href="https://fediscience.org/tags/EconTwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EconTwitter</span></a> <a href="https://fediscience.org/tags/statsodon" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>statsodon</span></a></p>
Peter Tennant, PhD<p>My request for 2023: stop using BMI. </p><p>If you're a member of the public, using it to suggest an 'ideal' weight: STOP.</p><p>If you're a clinician, using it to judge someone's weight: STOP.</p><p>If you're a scientist, using it as a proxy for adiposity: STOP.</p><p><a href="https://fediscience.org/tags/StopUsingBMI" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>StopUsingBMI</span></a> <a href="https://fediscience.org/tags/EpiTwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EpiTwitter</span></a></p>
Yea-Hung Chen<p>A brief <a href="https://sciences.social/tags/introduction" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>introduction</span></a>: I am an epidemiologist at the University of California, San Francisco (<a href="https://sciences.social/tags/ucsf" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ucsf</span></a>). My research focuses on disparities in <a href="https://sciences.social/tags/covid" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>covid</span></a> <a href="https://sciences.social/tags/mortality" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>mortality</span></a> (and <a href="https://sciences.social/tags/excessmortality" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>excessmortality</span></a>).</p><p>Some relevant hashtags: <a href="https://sciences.social/tags/epidemiology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epidemiology</span></a> <a href="https://sciences.social/tags/epi" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epi</span></a> <a href="https://sciences.social/tags/epitwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epitwitter</span></a> <a href="https://sciences.social/tags/publichealth" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>publichealth</span></a> <a href="https://sciences.social/tags/biostatistics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>biostatistics</span></a> <a href="https://sciences.social/tags/statistics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>statistics</span></a> <a href="https://sciences.social/tags/datascience" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>datascience</span></a> <a href="https://sciences.social/tags/r" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>r</span></a> <a href="https://sciences.social/tags/rstats" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>rstats</span></a> <a href="https://sciences.social/tags/teaching" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>teaching</span></a> <a href="https://sciences.social/tags/disparities" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>disparities</span></a> <a href="https://sciences.social/tags/healthdisparities" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>healthdisparities</span></a> <a href="https://sciences.social/tags/policy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>policy</span></a>.</p>
Flo Débarre<p>4️⃣ A group to follow to receive <a href="https://mstdn.science/tags/job" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>job</span></a> adverts in <a href="https://mstdn.science/tags/academia" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>academia</span></a> in <a href="https://mstdn.science/tags/Ecology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Ecology</span></a> or <a href="https://mstdn.science/tags/Evolution" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Evolution</span></a> </p><p><span class="h-card"><a href="https://a.gup.pe/u/jobsecoevo" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>jobsecoevo</span></a></span> </p><p>(thanks <span class="h-card"><a href="https://ecoevo.social/@anarodrigues" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>anarodrigues</span></a></span> for setting it up!)</p><p>Check <a href="https://a.gup.pe" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://</span><span class="">a.gup.pe</span><span class="invisible"></span></a> for creating similar group (also probably of interest for <a href="https://mstdn.science/tags/epiTwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epiTwitter</span></a>) <br><a href="https://mstdn.science/tags/FollowFriday" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>FollowFriday</span></a></p>
April Holland<p>Hi all, finding my way here. Epidemiologist turned local public health director... am I in the right place? </p><p>Also, how will I, a Gen Xer, survive here without GIFs? 😭</p><p><a href="https://med-mastodon.com/tags/publichealth" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>publichealth</span></a> <a href="https://med-mastodon.com/tags/epitwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epitwitter</span></a> <a href="https://med-mastodon.com/tags/epidemiology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epidemiology</span></a></p>
Peter Tennant, PhD<p>I have suggested <a href="https://fediscience.org/tags/EpiVerse" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EpiVerse</span></a> not as a replacement to <a href="https://fediscience.org/tags/EpiTwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EpiTwitter</span></a>, but simply as a space for epidemiologists to connect with each other and share thoughts, feelings, facts, and materials with other epidemiologists specifically. </p><p>Alternatively, I have suggested that we use the <a href="https://fediscience.org/tags/Epidemiology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Epidemiology</span></a> hashtag to share thoughts, feelings, facts, and materials with the wider world.</p><p>But people can, of course, use any hashtag they want for whatever purpose.</p><p><span class="h-card"><a href="https://aus.social/@jon_y_huang" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>jon_y_huang</span></a></span> <span class="h-card"><a href="https://mastodon.scot/@willball12" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>willball12</span></a></span> <span class="h-card"><a href="https://med-mastodon.com/@gregggonsalves" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>gregggonsalves</span></a></span> <span class="h-card"><a href="https://med-mastodon.com/@maciekboni" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>maciekboni</span></a></span></p>
Peter Tennant, PhD<p><a href="https://fediscience.org/tags/EpiTwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EpiTwitter</span></a> could also get lost up its causal-inference ass. I'm saying that as a big personal fan and active member of pre-pandemic <a href="https://fediscience.org/tags/EpiTwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EpiTwitter</span></a>, and someone with a passion for causal inference. But I was also branded a member of the 'causal mafia'. Someone who had a tendency to snarkily attack folks for publishing papers with Table 2 fallacies or without a DAG. While I think scientific criticism is important, my tone was often unfair.</p><p><span class="h-card"><a href="https://aus.social/@jon_y_huang" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>jon_y_huang</span></a></span> <span class="h-card"><a href="https://mastodon.scot/@willball12" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>willball12</span></a></span> <span class="h-card"><a href="https://med-mastodon.com/@gregggonsalves" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>gregggonsalves</span></a></span> <span class="h-card"><a href="https://med-mastodon.com/@maciekboni" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>maciekboni</span></a></span></p>
Peter Tennant, PhD<p><a href="https://fediscience.org/tags/EpiTwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EpiTwitter</span></a> had a rose-tinted age (best reflected here: <a href="https://academic.oup.com/aje/article/190/8/1625/6292357?login=true" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://</span><span class="ellipsis">academic.oup.com/aje/article/1</span><span class="invisible">90/8/1625/6292357?login=true</span></a>) but it died a traumatic death during the pandemic. There can be no <a href="https://fediscience.org/tags/EpiTwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EpiTwitter</span></a> 2.0 - in the same way we cannot unlearn our experiences of Twitter - because we cannot undo our collective experience in the past few years. That said, even before COVID-19, <a href="https://fediscience.org/tags/EpiTwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EpiTwitter</span></a> had problems, not least being a lack of diversity and the entrentchment of existing power networks</p><p><span class="h-card"><a href="https://aus.social/@jon_y_huang" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>jon_y_huang</span></a></span> <span class="h-card"><a href="https://mastodon.scot/@willball12" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>willball12</span></a></span> <span class="h-card"><a href="https://med-mastodon.com/@gregggonsalves" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>gregggonsalves</span></a></span> <span class="h-card"><a href="https://med-mastodon.com/@maciekboni" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>maciekboni</span></a></span></p>
Jon Huang<p><span class="h-card"><a href="https://mastodon.scot/@willball12" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>willball12</span></a></span> <span class="h-card"><a href="https://med-mastodon.com/@gregggonsalves" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>gregggonsalves</span></a></span> <span class="h-card"><a href="https://med-mastodon.com/@maciekboni" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>maciekboni</span></a></span> </p><p>*points to sign*</p><p>let's let folks caucus with their preferred hashtags 😅</p><p>i for one am ambivalent on <a href="https://aus.social/tags/EpiVerse" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EpiVerse</span></a> becoming <a href="https://aus.social/tags/EpiTwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>EpiTwitter</span></a> 2.0...</p>
Gregg Gonsalves<p>What should the new <a href="https://med-mastodon.com/tags/epitwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epitwitter</span></a> be called? As requested by <span class="h-card"><a href="https://med-mastodon.com/@maciekboni" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>maciekboni</span></a></span>.</p>
Gregg Gonsalves<p>So, trying to figure out where all the epidemiologists are. I see them here and there on this site, but there is nothing like <a href="https://med-mastodon.com/tags/epitwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epitwitter</span></a> yet. If you see an epidemiologist wandering around Mastodon, send them my way!</p>
Jon Huang<p>The reflex to indiscriminately stratify and adjust on covariates is strong in biomedical research. I face this so often, especially with clinician-scientist collaborators.</p><p>The analyses and models that arise from this, in fact, often do not well represent how exposures and treatments exert their effect in reality.</p><p>A <a href="https://aus.social/tags/TargetTrial" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>TargetTrial</span></a> approach crystallizes when, where, and how co-variates should be treated. </p><p>Take this great illustration from Target Trial originator <span class="h-card"><a href="https://fediscience.org/@MiguelHernan" class="u-url mention" rel="nofollow noopener noreferrer" target="_blank">@<span>MiguelHernan</span></a></span> where he explains the study design choices for study on COVID vaccine booster effectiveness:</p><p><a href="https://fediscience.org/@MiguelHernan/109331025655365201" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://</span><span class="ellipsis">fediscience.org/@MiguelHernan/</span><span class="invisible">109331025655365201</span></a></p><p><a href="https://aus.social/tags/epidemiology" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epidemiology</span></a> <a href="https://aus.social/tags/biostatistics" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>biostatistics</span></a> <a href="https://aus.social/tags/epitwitter" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epitwitter</span></a> <a href="https://aus.social/tags/statstodon" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>statstodon</span></a> <a href="https://aus.social/tags/epiVerse" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>epiVerse</span></a> @epiVerse</p>